CHD
34
7
BK
60
2
A
43
2
OKE
61
2
KR
50
5
PLD
35
5
RRC
52
2
EQIX
59
2
NEE
39
9
VRSN
59
4
QRVO
16
-6
CMA
42
3
VMC
41
2
DRI
74
5
COF
48
3
CMCSA
49
3
CI
35
2
PBI
30
-8
AMP
43
2
LRCX
56
4
CHD
34
7
BK
60
2
A
43
2
OKE
61
2
KR
50
5
PLD
35
5
RRC
52
2
EQIX
59
2
NEE
39
9
VRSN
59
4
QRVO
16
-6
CMA
42
3
VMC
41
2
DRI
74
5
COF
48
3
CMCSA
49
3
CI
35
2
PBI
30
-8
AMP
43
2
LRCX
56
4
Financhill
Back

Personalis Vs. Perspective Therapeutics Industry Stock Comparison

Buy
69

PSNL
Personalis

Last Price:
$5.76
Seasonality Move:
-17.16%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Buy
69
Personalis (PSNL) is a Buy

Is Personalis a Buy, Sell or Hold?

  • The current Personalis [PSNL] share price is $5.75. The Score for PSNL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • PSNL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSNL Stock Price Chart

What is Personalis's stock price today?

  • The Personalis share price today is $5.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSNL is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

PSNL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 69.32 Buy
Chaikin Money Flow: -6505191 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.39 - 4.41) Buy
Bollinger Bands (100): (3.89 - 5.55) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

PSNL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.16 Buy
20-day SMA: 3.97 Buy
50-day SMA: 4.39 Buy
200-day SMA: 3.15 Buy
8-day EMA: 4.45 Buy
20-day EMA: 4.18 Buy
50-day EMA: 4.3 Buy
200-day EMA: 3.55 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

Personalis Earnings Growth & PSNL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.76 per share, and an increase next year of $0.40 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Personalis Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):